|1.||Shakur, B Haleema: 1 article (01/2005)|
|2.||Beddoes, Ray J: 1 article (01/2005)|
|3.||Morrell, Nicholas W: 1 article (01/2005)|
|4.||Higham, Matthew A: 1 article (01/2005)|
|5.||Phillips, Peter G: 1 article (01/2005)|
|6.||Robinson, Paul J: 1 article (01/2005)|
|1.||Alcoholic Liver Diseases (Alcoholic Liver Disease)
|2.||Chronic Obstructive Pulmonary Disease (COPD)
|4.||Pulmonary Hypertension (Ayerza Syndrome)
01/01/2005 - "In this 12-month pilot study, losartan 50 mg had no statistically significant beneficial effect on TTPG, exercise capacity or symptoms in pulmonary hypertension secondary to obstructive disease. "
01/01/2005 - "Forty patients with COPD and pulmonary hypertension (Tran tricuspid pressure gradient (TTPG) = 30 mmHg) were randomised to losartan 50 mg or placebo. "
|5.||Delayed Hypersensitivity (Hypersensitivity, Type IV)
09/01/1993 - "Delayed hypersensitivity to stepronin: a case report."